Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348,651 | 198 | 83.4% |
| Travel and Lodging | $40,360 | 145 | 9.7% |
| Food and Beverage | $20,396 | 498 | 4.9% |
| Consulting Fee | $8,457 | 8 | 2.0% |
| Education | $68.38 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $112,762 | 181 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $96,996 | 134 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $89,087 | 151 | $0 (2024) |
| ABBVIE INC. | $47,525 | 113 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $37,436 | 80 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $24,336 | 42 | $0 (2019) |
| Lilly USA, LLC | $5,149 | 24 | $0 (2024) |
| IBSA Pharma Inc. | $1,058 | 5 | $0 (2024) |
| ROCHE DIABETES CARE, INC. | $777.00 | 1 | $0 (2024) |
| Sentynl Therapeutics, Inc. | $400.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,845 | 46 | ABBVIE INC. ($3,269) |
| 2023 | $2,929 | 36 | ABBVIE INC. ($1,863) |
| 2022 | $8,034 | 51 | AstraZeneca Pharmaceuticals LP ($5,647) |
| 2021 | $47,305 | 91 | AstraZeneca Pharmaceuticals LP ($16,391) |
| 2020 | $41,396 | 99 | SANOFI-AVENTIS U.S. LLC ($12,401) |
| 2019 | $65,616 | 143 | Novo Nordisk Inc ($19,701) |
| 2018 | $99,737 | 166 | Novo Nordisk Inc ($33,657) |
| 2017 | $148,069 | 222 | SANOFI-AVENTIS U.S. LLC ($40,621) |
All Payment Transactions
854 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Diabetes | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Cardio-renal | ||||||
| 12/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: Diabetes | ||||||
| 10/14/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 09/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $24.53 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Ultragenyx Pharmaceutical Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: XLH Metabolic Bone Disorder | ||||||
| 09/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $29.14 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.19 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Amneal Pharmaceuticals LLC | UNITHROID (Drug) | Food and Beverage | In-kind items and services | $28.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/19/2024 | ABBVIE INC. | SYNTHROID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: IMMUNOLOGY | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $38.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Diabetes | ||||||
| 07/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Cardio-renal | ||||||
| 06/28/2024 | ABBVIE INC. | SYNTHROID (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $33.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: DIABETES | ||||||
| 06/24/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,465 | 2,520 | $333,050 | $100,775 |
| 2022 | 11 | 770 | 1,164 | $257,133 | $81,787 |
| 2021 | 3 | 282 | 686 | $170,354 | $70,463 |
| 2020 | 3 | 331 | 696 | $172,212 | $61,169 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 300 | 616 | $207,673 | $58,679 | 28.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 69 | 83 | $39,305 | $12,279 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $15,736 | $4,736 | 30.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 141 | 259 | $10,878 | $4,244 | 39.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $11,644 | $3,469 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 52 | $12,292 | $3,428 | 27.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 128 | 208 | $6,864 | $2,702 | 39.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 142 | 258 | $5,934 | $2,263 | 38.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 134 | 237 | $5,688 | $2,237 | 39.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 135 | 242 | $5,082 | $2,006 | 39.5% |
| 80076 | Liver function blood test panel | Office | 2023 | 137 | 242 | $4,840 | $1,938 | 40.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 128 | 208 | $2,444 | $1,656 | 67.8% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 13 | 13 | $4,043 | $895.92 | 22.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 25 | 29 | $406.00 | $158.48 | 39.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 17 | 17 | $221.00 | $81.28 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 266 | 577 | $193,295 | $61,025 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 107 | $25,252 | $8,312 | 32.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 56 | 56 | $24,360 | $7,442 | 30.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 54 | 65 | $2,730 | $1,072 | 39.3% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 12 | 13 | $4,043 | $1,002 | 24.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 43 | 48 | $1,584 | $630.60 | 39.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 53 | 62 | $1,488 | $591.05 | 39.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 55 | 66 | $1,518 | $584.43 | 38.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 55 | 63 | $1,323 | $523.26 | 39.6% |
| 80076 | Liver function blood test panel | Office | 2022 | 49 | 57 | $1,140 | $457.29 | 40.1% |
About Dr. Chithranjan Nath, MD
Dr. Chithranjan Nath, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Fishkill, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1053456855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chithranjan Nath, MD has received a total of $417,932 in payments from pharmaceutical and medical device companies, with $4,845 received in 2024. These payments were reported across 854 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($348,651).
As a Medicare-enrolled provider, Nath has provided services to 2,848 Medicare beneficiaries, totaling 5,066 services with total Medicare billing of $314,194. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Fishkill, NY
- Active Since 02/20/2007
- Last Updated 05/31/2022
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1053456855
Products in Payments
- FARXIGA (Drug) $81,735
- JARDIANCE (Drug) $42,487
- SOLIQUA (Drug) $37,000
- Tresiba (Drug) $28,064
- TOUJEO (Drug) $23,786
- Ozempic (Drug) $22,780
- Victoza (Drug) $22,772
- SOLIQUA 100/33 (Biological) $22,576
- Synthroid (Drug) $19,090
- SYNTHROID (Drug) $17,198
- RYBELSUS (Drug) $14,456
- JANUVIA (Drug) $11,150
- STEGLATRO (Drug) $9,701
- SOLIQUA 100/33 (Drug) $8,670
- Androgel (Drug) $8,472
- BYDUREON (Drug) $7,352
- Xultophy 100/3.6 (Drug) $5,675
- TOUJEO (Biological) $4,946
- Tirosint (Drug) $1,058
- Accu-Chek Guide (Device) $777.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Fishkill
Dr. Meryl Reichman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $610.77
Delia Stefan, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $45.39
Dr. Laila Noor, Md, MD
Endocrinology, Diabetes & Metabolism